Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?—findings from the ESC CRT Survey II-Reference-Cited by-同舟云学术

Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?—findings from the ESC CRT Survey II

Published:2019-02-13 Issue:6 Volume:21 Page:918-927
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Normand Camilla¹²,Linde Cecilia³,Bogale Nigussie¹,Blomström-Lundqvist Carina⁴,Auricchio Angelo⁵,Stellbrink Christoph⁶,Witte Klaus K⁷,Mullens Wilfried⁸⁹,Sticherling Christian¹⁰,Marinskis Germanas¹¹,Sciaraffia Elena⁴,Papiashvili Giorgi¹²,Iovev Svetoslav¹³,Dickstein Kenneth¹²

Affiliation:

1. Cardiology Division, Stavanger University Hospital, Stavanger, Norway

2. Institute of Internal Medicine, University of Bergen, Bergen, Norway

3. Heart and Vascular Theme, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

4. Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden

5. Clinical Electrophysiology Unit, Fondazione Cardiocentro Ticino, Lugano, Switzerland

6. Department of Cardiology, Klinikum Bielefeld, Germany

7. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds

8. Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium

9. Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium

10. University Hospital Basel, University of Basel, Switzerland

11. Clinic of Heart Diseases, Vilnius University, Lithuania

12. Arrhythmia Department, Helsicore - Israeli-Georgian Medical Research Clinic, Tbilisi, Georgia

13. Cardiostimulation and Electrophysiology sector at “St. Ekaterina” University Multi-profile Hospital for Active Treatment, Sofia, Bulgaria

Funder

European Heart Rhythm Association

Heart Failure Association

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/21/6/918/28736985/euz002.pdf

Reference21 articles.

1. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA);Brignole;Europace,2013

2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Ponikowski;Eur Heart J,2016

3. Indications for cardiac resynchronization therapy: a comparison of the major international guidelines;Normand;JACC Heart Fail,2018

4. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?;Dickstein;Eur J Heart Fail,2018

5. The European cardiac resynchronization therapy survey;Dickstein;Eur Heart J,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is conduction system pacing a panacea for pacemaker therapy?;Expert Review of Medical Devices;2024-06-24

2. When Is Cardiac Resynchronization Therapy with a Defibrillator Indicated in Patients with Heart Failure, Especially Elderly Patients?;International Heart Journal;2023-05-31

3. What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II;European Heart Journal - Quality of Care and Clinical Outcomes;2023-04-19

4. Mapping the research trends and hot topics of ventricular arrhythmia: A bibliometric analysis from 2001 to 2020;Frontiers in Cardiovascular Medicine;2022-10-20

5. Follow-up and characteristics of recipients of cardiac resynchronization therapy with and without a defibrillator;Kardiologia Polska;2022-08-31